CANNABINOIDS IN EPILEPSY

CANNABINOIDS IN EPILEPSY

Epilepsy is one of the most common neurological disorders, affecting around 70 million people worldwide. 65% of patients are managed with antiepileptic drugs and lead a normal life but, what about the remaining 35%? These patients suffer from refractory epilepsy,...
Robert Hoban, Global Cannabis Industry Expert.

Robert Hoban, Global Cannabis Industry Expert.

What benefits do you think the implementation of the regulation of medical cannabis in Spain could bring? The nationwide commercial regulation of cannabis provides many benefits that are distinct from merely allowing businesses to exist, like the present status quo in...
The expert opinion by Raúl Fernandez, Technical Director at Labsom

The expert opinion by Raúl Fernandez, Technical Director at Labsom

Which aspect of the GMP design of a medical cannabis industry requires the most attention? I would say the most critical aspect focuses on ensuring strict control of environmental conditions. Maintaining a controlled environment is crucial to ensure product quality,...
The expert opinion by María Pérez Rey, R&D Project Manager at CTAEX

The expert opinion by María Pérez Rey, R&D Project Manager at CTAEX

What is the importance of empirical data in the cannabis industry? The existence of sufficient scientific evidence is a recurring debate within the industry. At present, there is a duality of opinion regarding such evidence for the therapeutic use of cannabis that...
The expert opinion by Mar Díaz, Technical Validation Manager at Trescal

The expert opinion by Mar Díaz, Technical Validation Manager at Trescal

What would be the best implementation or improvement Trescal would recommend for a medical Cannabis facility? The adoption of a proper GACP/GMP/GDP compliant Quality Management System (depending on the targeted activity, cultivation, harvesting, cutting, processing,...